@article{36b541b8eeb6475d859ff421f7d0c23b,
title = "Warmer outdoor temperature is associated with task-related increased BOLD activation in patients with multiple sclerosis",
abstract = "Patients with multiple sclerosis (MS) demonstrate worse cognition on warmer days. Here, we examine the neurophysiology underlying this temperature-cognition relationship. The association between task-related BOLD fMRI activation and outdoor temperature was investigated in 28 MS patients who demonstrated worse cognitive function on warmer days. In MS patients, warmer outdoor temperature was associated with greater BOLD activation during performance of a simple sustained attention task. The brain areas that showed greater activation on warmer days (p =.01) were regions that have been shown to be more activated by MS patients during task performance: frontal, dorsolateral prefrontal, and parietal cortex. The relationship between outdoor temperature and cerebral activation was absent in healthy controls. The purpose of this study was to identify the neurophysiological basis for worse cognition among MS patients on warmer days. We show here that MS patients activate task-related brain regions more on warmer days. Increased brain activation required by MS patients on warmer days to perform a simple task may signify neural inefficiency.",
keywords = "Cognition, Functional neuroimaging, Memory, Multiple sclerosis, Temperature, fMRI",
author = "Leavitt, {Victoria M.} and Glenn Wylie and Nancy Chiaravalloti and John DeLuca and Sumowski, {James F.}",
note = "Funding Information: Acknowledgments Dr. Leavitt is funded by grants from the National Multiple Sclerosis Society (RG4810A1/1, PP1854) and the New Jersey Commission on Brain Injury Research. Dr. Wylie is funded by a grant from the NJ Commission on Brain Injury Research (103216BIRE0). Dr. Chiaravalloti is funded by grants from the National Multiple Sclerosis Society (RG3330A1/3, RG4607A3), NIDRR (H133A070037 and H133G090078), and US Dept of Education (H133P070007). She has received salary support through compensation to the Kessler Foundation Research Center from Memen Pharmaceuticals, LLC. Dr. DeLuca is funded by grants from the National Multiple Sclerosis Society (MB003), NIDRR (H133a070037), Biogen Idec, and Memen Pharmaceuticals. He has received salary support through compensation to the Kessler Foundation Research Center from Memen Pharmaceuticals, LLC. Dr. DeLuca works as a consultant for Biogen Idec and Memen Pharmaceuticals. Dr. Sumowski is funded by a grant from the NIH (R00HD060765). He has received salary support through compensation to the Kessler Foundation Research Center from Memen Pharmaceuticals, LLC.",
year = "2014",
month = mar,
doi = "10.1007/s11682-013-9267-7",
language = "English",
volume = "8",
pages = "128--132",
journal = "Brain Imaging and Behavior",
issn = "1931-7557",
publisher = "Springer New York",
number = "1",
}